Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02101385
Recruitment Status : Recruiting
First Posted : April 2, 2014
Last Update Posted : February 8, 2018
Hoosier Cancer Research Network
Vera Bradley Foundation for Breast Cancer
Walther Cancer Institute
Strategic Research Initiative Grant through IUSCC
Information provided by (Responsible Party):
Bryan Schneider, MD, Hoosier Cancer Research Network

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : June 2021
  Estimated Study Completion Date : December 2021